Dr. Lydia Frick is a Manager Market Access at SKC Beratungsgesellschaft mbH, a leading strategic consultancy located in Hannover, Germany, covering full market access of pharmaceuticals and digital health applications in Germany and Europe. As a psychologist, natural scientist and market access expert, Lydia combines a deep understanding of the generation of clinical evidence with strong strategic insights from the perspectives of developers, HTA bodies, and payers.
Lydia has a BSc and MSc in Psychology from the University of Goettingen and did her PhD in Cognitive Neuroscience at German Primate Center in Goettingen. She then started her career outside academia as a medical writer focusing on the compilation of value dossiers for the German AMNOG benefit assessment. Moving into strategic consulting, Lydia has gained extensive experience with market access including AMNOG and EU-HTA strategy, with a particular focus on orphan drugs and ATMPs.